PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629201
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629201
Endovascular Aneurysm Repair Market size was valued at US$ 3,567.12 Million in 2024, expanding at a CAGR of 4.9% from 2025 to 2032.
The Endovascular Aneurysm Repair (EVAR) Market involves minimally invasive procedures used to treat abdominal and thoracic aortic aneurysms by placing a stent graft to reinforce weakened artery walls. The rising prevalence of aortic aneurysms, which affect around 2-3% of the global population, has increased the demand for effective, less invasive treatments. Technological advancements in stent graft designs, such as hybrid and fenestrated devices, have improved clinical outcomes and reduced procedural risks, further driving the market. However, high treatment costs, limited availability of skilled professionals, and complications associated with endovascular procedures such as endoleaks present challenges. Opportunities are emerging in the expansion of healthcare access in developing regions, where the increasing awareness of cardiovascular diseases and improving healthcare infrastructure are boosting demand for EVAR procedures. Additionally, advancements in imaging techniques and robotic-assisted surgeries are expected to enhance the precision and success rates of EVAR, creating new growth avenues in the market.
Endovascular Aneurysm Repair Market- Market Dynamics
Technological Advancements in Stent Graft Designs Drive Growth in the Endovascular Aneurysm Repair Market
Technological advancements in stent graft designs are significantly driving growth in the Endovascular Aneurysm Repair (EVAR) Market, as innovations improve treatment outcomes and reduce complications. For example, the U.S. National Institutes of Health (NIH) reports that over 200,000 people annually in the U.S. are diagnosed with aortic aneurysms, a condition that often requires surgical intervention. Advances such as fenestrated and branched stent grafts enable more precise repairs, even in complex cases, reducing the need for open surgery. The improved designs also lead to shorter recovery times and fewer complications, enhancing patient outcomes. Additionally, the American Heart Association highlights that minimally invasive techniques, like EVAR, have reduced the mortality rate of aortic aneurysm repairs by up to 40%. These innovations are not only improving clinical success but also expanding treatment options, creating a favorable environment for the continued growth of the EVAR market.
Endovascular Aneurysm Repair Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.9% over the forecast period (2025-2032)
Based on product type segmentation, Abdominal Aortic Aneurysm (AAA) Stent Grafts was predicted to show maximum market share in the year 2024
Based on Anatomy segmentation, Traditional was the leading Anatomy in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Endovascular Aneurysm Repair Market is segmented based on Product Type, Anatomy, Material, End-User, and Region.
The market is divided into six categories based on product type: Abdominal Aortic Aneurysm (AAA) Stent Grafts, Thoracic Aortic Aneurysm (TAA) Stent Grafts, Fenestrated Stent Grafts, Percutaneous Evar, Fenestrated Evar, and Aortic Stents & Taa Graft. Abdominal Aortic Aneurysm (AAA) Stent Grafts lead the market due to their widespread use in treating aortic aneurysms, followed by Thoracic Aortic Aneurysm (TAA) Stent Grafts. Fenestrated Stent Grafts and Fenestrated EVAR are gaining traction, with Percutaneous EVAR and Aortic Stents & TAA Grafts holding secondary importance.
The market is divided into two categories based on Anatomy: Traditional and Complex. Traditional anatomy procedures lead the market due to their broader application in standard aneurysm cases, followed by Complex anatomy procedures, which are increasingly gaining traction for treating challenging cases, such as those with multiple branches or difficult anatomical configurations.
Endovascular Aneurysm Repair Market- Geographical Insights
The Endovascular Aneurysm Repair (EVAR) Market is geographically diverse, with North America and Europe holding dominant market shares due to advanced healthcare infrastructure, high awareness of cardiovascular diseases, and favorable reimbursement policies. In the U.S., the increasing ageing population and growing incidence of aortic aneurysms have propelled the demand for EVAR procedures, with more than 200,000 abdominal aortic aneurysm (AAA) surgeries performed annually, according to the Centers for Disease Control and Prevention (CDC). Europe also experiences substantial growth, driven by countries like Germany, France, and the UK, where healthcare systems emphasize minimally invasive treatments. The Asia-Pacific region is witnessing rapid growth, with increasing healthcare access, urbanization, and a rise in cardiovascular conditions. Countries like Japan, China, and India are emerging as key players, as improving healthcare systems and the expansion of EVAR procedures gain traction. Meanwhile, regions like Latin America and the Middle East have shown slower adoption rates, but the growing awareness of aortic aneurysm risks and government healthcare investments are expected to foster market growth in the coming years.
The Endovascular Aneurysm Repair (EVAR) Market is highly competitive, with several key players leading the industry through technological innovations and strategic expansions. Major companies such as Medtronic, Cook Medical, Johnson & Johnson, and Becton Dickinson dominate the market, offering a wide range of stent grafts and devices for aortic aneurysm repair. These companies focus on enhancing product quality, such as developing fenestrated and branched stent grafts that cater to complex aneurysm cases, which has expanded their market share. Strategic partnerships, acquisitions, and collaborations are common in the market. For instance, Medtronic acquired Mazor Robotics to incorporate robotic assistance into their endovascular procedures, aiming to improve precision and outcomes. Smaller, innovative players are entering the market with niche products targeting specific regions or patient needs, increasing competition. The market also sees the rise of companies focusing on developing advanced imaging systems and next-generation graft materials to improve the success rates of EVAR procedures. Overall, the competition is characterized by continuous product innovation, regulatory approvals, and expanding geographical reach to meet the rising demand for minimally invasive treatments.
In August 2024, Terumo India launched the TREO Stent-Graft System, a treatment option for abdominal aortic aneurysms in adults. The TREO system is designed for infrarenal abdominal aortic aneurysms and is the only EVAR graft with both suprarenal and infrarenal active fixation.
In June 2024, Medtronic introduced the Steerant Aortic Guidewire, designed to enhance the precision and ease of Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (TEVAR) procedures, improving outcomes and procedural efficiency.